Report
Oliver Metzger

Amplifon : Q1 review - the usual beat, guidance with moderate upside

>Solid top line development supported by recovery of global hearing aid market - Amplifon reported Q1 revenue of € 540.3m (+9.0% y-o-y), +3%/2% vs ODDO BHF/consensus. Sales growth in local currencies was 9.3% (vs 6.3% est.). Organic growth was 7.4%, supported by a recovering global hearing aid market. Acquisitions contributed 190bp, while forex accounted for a tailwind of 30bp. Europe performed solidly, with 6% growth in constant currencies. The Americas region was u...
Underlying
Amplifon S.p.A.

Amplifon is multinational company engaged in the ddistribution, fitting, adaptation and personalization of hearing systems (hearing aids) designed to meet the needs of those suffering from hearing disabilities. Co. is also engaged in the sale of accessories such as batteries, consumables and spare parts, as well as in the distribution of biomedical devices. Co. is active in 20 different countries: Italy, France, Germany, Switzerland, The Netherlands, Belgium, Luxembourg, the U.K., Ireland, Spain, Portugal, Hungary, Turkey, the U.S., Canada, Australia, New Zealand, India, Egypt, and in Poland.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Oliver Metzger

ResearchPool Subscriptions

Get the most out of your insights

Get in touch